In 2021-22 we continued to take a lead role in adapting to the health environment that has been significantly impacted by COVID-19. Medicines and medical devices associated with COVID-19 were prioritised and their safety and efficacy assessed through stringent pre-market assessments and thorough post-market safety monitoring. Post-market review of COVID-19-related devices including face masks, respirators, and test kits was also a major activity.
The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.